Top Markets
#1 Helium Helium +54.86%
#2 GEKKO GEKKO +52.86%
#3 ADO Protocol ADO Protocol +38.95%
#4 StonkBroker StonkBroker +36.73%
#5 Pons Pons +36.17%
#6 TENDIES TENDIES +35.28%
#7 Prom Prom +30.65%
#8 Collector Crypt Collector Crypt +29.96%
#9 o1.exchange o1.exchange +21.00%
#10 Cysic Cysic +20.09%
Coin of the day
Helium Helium
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Chengdu Kanghua Biological Products Co., Ltd. Chengdu Kanghua Biological Products Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd.

300841
Rangering i aksjer #9575
Chengdu Kanghua Biological Products Co., Ltd. engages in the research,... Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
Aksjekurs
$7.60
Sist synkronisert: 2026-08-28
Markedsverdi
$987.13M
Endring (1 dag)
-5.04%
Endring (1 år)
-28.09%
Land
CN
Handel Chengdu Kanghua Biological Products Co., Ltd. (300841)

Kategori

Healthcare
Aksjeprishistorikk for Chengdu Kanghua Biological Products Co., Ltd. (300841)
Høyeste sluttskurs: $7.53 den 2026-08-01

Laveste sluttskurs: $9.58 den 2020-06-01
Aksjeprishistorikk for Chengdu Kanghua Biological Products Co., Ltd. fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -16.00%
2025 37.71%
2024 -22.82%
2023 -19.13%
2022 -29.54%
2021 -43.13%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH